4//SEC Filing
Chopas James George 4
Accession 0001127602-25-001614
CIK 0001492422other
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 3:56 PM ET
Size
6.2 KB
Accession
0001127602-25-001614
Insider Transaction Report
Form 4
Chopas James George
VP/Chief Accounting Officer
Transactions
- Award
Common Stock
2025-01-21+12,591→ 49,234 total - Sale
Common Stock
2025-01-17$29.96/sh−715$21,420→ 36,643 total
Footnotes (2)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 16, 2025.
- [F2]This represents a Restricted Stock Unit award granted on January 21, 2025 that vest 25% annually over four years from grant date subject to continued service.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001836430
Filing Metadata
- Form type
- 4
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 3:56 PM ET
- Size
- 6.2 KB